Redox signaling pathways involved in neuronal ischemic preconditioning

Current Neuropharmacology

Volumn 10, Issue 4, 2012, Pages 354-369

  Thompson, John W ^a   Narayanan, Srinivasan V ^a   Perez Pinzon, Miguel A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Epsilon PKC; HIF; Ischemic preconditioning; Nrf2; Reactive oxygen species; Reperfusion; SIRT1; Sirtuin

Indexed keywords

ANTIOXIDANT; CARBON MONOXIDE; DIAZOXIDE; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1; MITOCHONDRIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE C EPSILON; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UBIDECARENONE;

APOPTOSIS; BRAIN ISCHEMIA; CELL DEATH; HUMAN; ISCHEMIC PRECONDITIONING; LIPID OXIDATION; NEUROPROTECTION; NONHUMAN; REDOX SIGNALING; REVIEW; SIGNAL TRANSDUCTION;

EID: 84874864664     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159x11209040354     Document Type: Review

References (188)

1. Flamm, E.S.; Demopoulos, H.B.; Seligman, M.L.; Poser, R.G.; Ransohoff, J. Free radicals in cerebral ischemia. Stroke, 1978, 9(5), 445-447.
2. Liou, A.K.; Clark, R.S.; Henshall, D.C.; Yin, X.M.; Chen, J. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol., 2003, 69(2), 103-142.
3. Murphy, A.N.; Fiskum, G.; Beal, M.F. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J. Cereb. Blood Flow Metab., 1999, 19(3), 231-245.
4. Perez-Pinzon, M.A.; Mumford, P.L.; Rosenthal, M.; Sick, T.J. Antioxidants, mitochondrial hyperoxidation and electrical recovery after anoxia in hippocampal slices. Brain Res., 1997, 754(1-2), 163-170.
5. Perez-Pinzon, M.A.; Xu, G.P.; Dietrich, W.D.; Rosenthal, M.; Sick, T.J. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood. Flow. Metab., 1997, 17(2), 175-182.
6. Rosenthal, M.; Feng, Z.C.; Raffin, C.N.; Harrison, M.; Sick, T.J. Mitochondrial hyperoxidation signals residual intracellular dysfunction after global ischemia in rat neocortex. J. Cereb. Blood Flow Metab., 1995, 15(4), 655-665.
7. Rosenthal, M.; Mumford, P.L.; Sick, T.J.; Perez-Pinzon, M.A. Mitochondrial hyperoxidation after cerebral anoxia/ischemia. Epiphenomenon or precursor to residual damage? Adv. Exp. Med. Biol., 1997, 428, 189-195.
8. Welsh, F.A.; Marcy, V.R.; Sims, R.E. NADH fluorescence and regional energy metabolites during focal ischemia and reperfusion of rat brain. J. Cereb. Blood Flow Metab., 1991, 11(3), 459-465.
9. Welsh, F.A.; Vannucci, R.C.; Brierley, J.B. Columnar alterations of NADH fluorescence during hypoxia-ischemia in immature rat brain. J. Cereb. Blood. Flow Metab., 1982, 2(2), 221-228.
10. Perez-Pinzon, M.A.; Xu, G.P.; Born, J.; Lorenzo, J.; Busto, R.; Rosenthal, M.; Sick, T.J. Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J. Cereb. Blood Flow Metab., 1999, 19(1), 39-43.
11. Raval, A.P.; Dave, K.R.; Prado, R.; Katz, L.M.; Busto, R.; Sick, T.J.; Ginsberg, M.D.; Mochly-Rosen, D.; Perez-Pinzon, M.A. Protein kinase C delta cleavage initiates an aberrant signal transduction pathway after cardiac arrest and oxygen glucose deprivation. J. Cereb. Blood Flow Metab., 2005, 25(6), 730-741.
12. Fridovich, I. Hypoxia and oxygen toxicity. Adv. Neurol., 1979, 26, 255-259.
13. Kontos, H.A. Oxygen radicals in CNS damage. Chem. Biol. Interact., 1989, 72(3), 229-255.
14. Vlessis, A.A.; Widener, L.L.; Bartos, D. Effect of peroxide, sodium, and calcium on brain mitochondrial respiration in vitro: potential role in cerebral ischemia and reperfusion. J. Neurochem., 1990, 54(4), 1412-1418.
15. Boyle, E. M, Jr.; Pohlman, T.H.; Cornejo, C.J.; Verrier, E.D. Endothelial cell injury in cardiovascular surgery: ischemiareperfusion. Ann. Thorac. Surg., 1996, 62(6), 1868-1875.
16. Jennings, R.B.; Schaper, J.; Hill, M.L.; Steenbergen, C., Jr.; Reimer, K.A. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ. Res., 1985, 56(2), 262-278.
17. Jennings, R.B.; Steenbergen, C., Jr.; Reimer, K.A. Myocardial ischemia and reperfusion. Monogr. Pathol., 1995, 37, 47-80.
18. Siesjo, B.K. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J. Neurosurg., 1992, 77(3), 337-354.
19. Allen, B.S.; Ko, Y.; Buckberg, G.D.; Tan, Z. Studies of isolated global brain ischaemia: II. Controlled reperfusion provides complete neurologic recovery following 30 min of warm ischaemia-the importance of perfusion pressure. Eur. J. Cardiothorac. Surg., 2012.
20. Perez-Pinzon, M.A.; Mumford, P.L.; Rosenthal, M.; Sick, T.J. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience, 1996, 75(3), 687-694.
21. Ohtsuki, T.; Ruetzler, C.A.; Tasaki, K.; Hallenbeck, J.M. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood. Flow. Metab., 1996, 16(6), 1137-1142.
22. Nawashiro, H.; Martin, D.; Hallenbeck, J.M. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res., 1997, 778(2), 265-271.
23. Pugliese, A.M.; Latini, S.; Corradetti, R.; Pedata, F. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br. J. Pharmacol., 2003, 140(2), 305-314.
24. Gross, G.J.; Auchampach, J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res., 1992, 70(2), 223-233.
25. Auchampach, J.A.; Gross, G.J. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am. J. Physiol., 1993, 264(5 Pt 2), H1327-1336.
26. Auchampach, J.A.; Maruyama, M.; Cavero, I.; Gross, G.J. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J. Pharmacol. Exp. Ther., 1991, 259(3), 961-967.
27. Blondeau, N.; Plamondon, H.; Richelme, C.; Heurteaux, C.; Lazdunski, M. K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience, 2000, 100(3), 465-474.
28. Perez-Pinzon, M.A.; Born, J.G. Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience, 1999, 89(2), 453-459.
29. Ohtsuki, T.; Matsumoto, M.; Kuwabara, K.; Kitagawa, K.; Suzuki, K.; Taniguchi, N.; Kamada, T. Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons. Brain Res., 1992, 599(2), 246-252.
30. Zhao, Y.; Zhao, B. Protective effect of natural antioxidants on heart against ischemia-reperfusion damage. Curr. Pharm. Biotechnol., 2010, 11(8), 868-874.
31. Zhang, Y.; Sano, M.; Shinmura, K.; Tamaki, K.; Katsumata, Y.; Matsuhashi, T.; Morizane, S.; Ito, H.; Hishiki, T.; Endo, J.; Zhou, H.; Yuasa, S.; Kaneda, R.; Suematsu, M.; Fukuda, K. 4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. J. Mol. Cell. Cardiol., 2010, 49(4), 576-586.
32. Philipson, K.A.; Elder, M.G.; White, J.O. The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma. J. Steroid. Biochem., 1985, 23(6A), 1059-1064.
33. Piantadosi, C.A.; Zhang, J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke, 1996, 27(2), 327-331; discussion 332.
34. Oliver, C.N.; Starke-Reed, P.E.; Stadtman, E.R.; Liu, G.J.; Carney, J.M.; Floyd, R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci., U S A, 1990, 87(13), 5144-5147.
35. Ambrosio, G.; Tritto, I.; Chiariello, M. The role of oxygen free radicals in preconditioning. J. Mol. Cell. Cardiol., 1995, 27(4), 1035-1039.
36. Baines, C.P.; Goto, M.; Downey, J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell. Cardiol., 1997, 29(1), 207-216.
37. Chen, W.; Gabel, S.; Steenbergen, C.; Murphy, E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ. Res., 1995, 77(2), 424-429.
38. McPherson, B.C.; Yao, Z. Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation, 2001, 103(2), 290-295.
39. Tritto, I.; D'Andrea, D.; Eramo, N.; Scognamiglio, A.; De Simone, C.; Violante, A.; Esposito, A.; Chiariello, M.; Ambrosio, G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ. Res., 1997, 80(5), 743-748.
40. Das, D.K.; Maulik, N. Preconditioning potentiates redox signaling and converts death signal into survival signal. Arch. Biochem. Biophys., 2003, 420(2), 305-311.
41. Saldiva, P.H.; Massad, E.; Caldeira, M.P.; Calheiros, D.F.; Saldiva, C.D.; Bohm, G.M. The study of mechanical properties of rats lungs by whole body plethysmography. Acta. Physiol. Pharmacol. Latinoam., 1985, 35(1), 109-117.
42. Puisieux, F.; Deplanque, D.; Bulckaen, H.; Maboudou, P.; Gele, P.; Lhermitte, M.; Lebuffe, G.; Bordet, R. Brain ischemic preconditioning is abolished by antioxidant drugs but does not upregulate superoxide dismutase and glutathion peroxidase. Brain Res., 2004, 1027(1-2), 30-37.
43. Liu, J.; Narasimhan, P.; Yu, F.; Chan, P.H. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke, 2005, 36(6), 1264-1269.
44. Raval, A.P.; Dave, K.R.; DeFazio, R.A.; Perez-Pinzon, M.A. epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res., 2007, 1184, 345-353.
45. Obata, T.; Yamanaka, Y. Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium. Arch. Biochem. Biophys., 2000, 378(2), 195-200.
46. Schultz, J.E.; Qian, Y.Z.; Gross, G.J.; Kukreja, R.C. The ischemiaselective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol., 1997, 29(3), 1055-1060.
47. Forbes, R.A.; Steenbergen, C.; Murphy, E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ. Res., 2001, 88(8), 802-809.
48. Carroll, R.; Gant, V.A.; Yellon, D.M. Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc. Res., 2001, 51(4), 691-700.
49. Liang, H.W.; Xia, Q.; Bruce, I.C. Reactive oxygen species mediate the neuroprotection conferred by a mitochondrial ATP-sensitive potassium channel opener during ischemia in the rat hippocampal slice. Brain Res., 2005, 1042(2), 169-175.
50. Rao, S.; Lin, Z.; Drobyshevsky, A.; Chen, L.; Ji, X.; Ji, H.; Yang, Y.; Yu, L.; Derrick, M.; Silverman, R.B.; Tan, S. Involvement of neuronal nitric oxide synthase in ongoing fetal brain injury following near-term rabbit hypoxia-ischemia. Dev. Neurosci., 2011, 33(3-4), 288-298.
51. Jones, S.P.; Greer, J.J.; Kakkar, A.K.; Ware, P.D.; Turnage, R.H.; Hicks, M.; van Haperen, R.; de Crom, R.; Kawashima, S.; Yokoyama, M.; Lefer, D.J. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am. J. Physiol. Heart. Circ. Physiol., 2004, 286(1), H276-282.
52. Bertrand, X.; Costa, Y.; Pina, P. Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003. Med. Mal. Infect., 2005, 35(6), 329-334.
53. Cassina, A.; Radi, R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys., 1996, 328(2), 309-316.
54. Nadtochiy, S.M.; Burwell, L.S.; Brookes, P.S. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemiareperfusion injury. J. Mol. Cell. Cardiol., 2007, 42(4), 812-825.
55. Burwell, L.S.; Nadtochiy, S.M.; Tompkins, A.J.; Young, S.; Brookes, P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J., 2006, 394(Pt 3), 627-634.
56. Palacios-Callender, M.; Quintero, M.; Hollis, V.S.; Springett, R.J.; Moncada, S. Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A., 2004, 101(20), 7630-7635.
57. Zhang, J.; Jin, B.; Li, L.; Block, E.R.; Patel, J.M. Nitric oxideinduced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am. J. Physiol. Cell. Physiol., 2005, 288(4), C840-849.
58. Cho, D.H.; Nakamura, T.; Fang, J.; Cieplak, P.; Godzik, A.; Gu, Z.; Lipton, S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science, 2009, 324(5923), 102-105.
59. Scherz-Shouval, R.; Shvets, E.; Fass, E.; Shorer, H.; Gil, L.; Elazar, Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO. J., 2007, 26(7), 1749-1760.
60. Quijano, C.; Alvarez, B.; Gatti, R.M.; Augusto, O.; Radi, R. Pathways of peroxynitrite oxidation of thiol groups. Biochem. J., 1997, 322 (Pt 1), 167-173.
61. Radi, R.; Rodriguez, M.; Castro, L.; Telleri, R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys., 1994, 308(1), 89-95.
62. Moreno, D.M.; Marti, M.A.; De Biase, P.M.; Estrin, D.A.; Demicheli, V.; Radi, R.; Boechi, L. Exploring the molecular basis of human manganese superoxide dismutase inactivation mediated by tyrosine 34 nitration. Arch. Biochem. Biophys., 2011, 507(2), 304-309.
63. MacMillan-Crow, L.A.; Thompson, J.A. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch. Biochem. Biophys., 1999, 366(1), 82-88.
64. Schmidt, P.; Youhnovski, N.; Daiber, A.; Balan, A.; Arsic, M.; Bachschmid, M.; Przybylski, M.; Ullrich, V. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J. Biol. Chem., 2003, 278(15), 12813-12819.
65. Bachschmid, M.; Thurau, S.; Zou, M.H.; Ullrich, V. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB. J., 2003, 17(8), 914-916.
66. Schildknecht, S.; Pape, R.; Muller, N.; Robotta, M.; Marquardt, A.; Burkle, A.; Drescher, M.; Leist, M. Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J. Biol. Chem., 2011, 286(7), 4991-5002.
67. Hall, E.D.; Detloff, M.R.; Johnson, K.; Kupina, N.C. Peroxynitritemediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J. Neurotrauma, 2004, 21(1), 9-20.
68. van der Veen, R.C.; Roberts, L.J. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol., 1999, 95(1-2), 1-7.
69. Stevens, J.F.; Miranda, C.L.; Frei, B.; Buhler, D.R. Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha, beta-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore. Chem. Res. Toxicol., 2003, 16(10), 1277-1286.
70. Szabo, E.; Virag, L.; Bakondi, E.; Gyure, L.; Hasko, G.; Bai, P.; Hunyadi, J.; Gergely, P.; Szabo, C. Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J. Invest. Dermatol., 2001, 117(1), 74-80.
71. Chen, W.; Li, Y.; Li, J.; Han, Q.; Ye, L.; Li, A. Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation. Food. Chem. Toxicol., 2011, 49(9), 2439-2444.
72. Abraham, P.; Rabi, S. Protein nitration, PARP activation and NAD+ depletion may play a critical role in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis in the rat. Cancer Chemother. Pharmacol., 2009, 64(2), 279-285.
73. Altup, S.; Demiryurek, A.T.; Ak, D.; Tungel, M.; Kanzik, I. Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur. J. Pharmacol., 2001, 415(2-3), 239-246.
74. Csonka, C.; Csont, T.; Onody, A.; Ferdinandy, P. Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem. Biophys. Res. Commun., 2001, 285(5), 1217-1219.
75. Kinuta, Y.; Kimura, M.; Itokawa, Y.; Ishikawa, M.; Kikuchi, H. Changes in xanthine oxidase in ischemic rat brain. J. Neurosurg., 1989, 71(3), 417-420.
76. De Vos, K.J.; Chapman, A.L.; Tennant, M.E.; Manser, C.; Tudor, E.L.; Lau, K.F.; Brownlees, J.; Ackerley, S.; Shaw, P.J.; McLoughlin, D.M.; Shaw, C.E.; Leigh, P.N.; Miller, C.C.; Grierson, A.J. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet., 2007, 16(22), 2720-2728.
77. Kudin, A.P.; Augustynek, B.; Lehmann, A.K.; Kovacs, R.; Kunz, W.S. The contribution of thioredoxin-2 reductase and glutathione peroxidase to H(2)O(2) detoxification of rat brain mitochondria. Biochim. Biophys. Acta., 2012. [Epub ahead of print].
78. Hwang, I.; Lee, J.; Huh, J.Y.; Park, J.; Lee, H.B.; Ho, Y.S.; Ha, H. Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes, 2012, 61(3), 728-738.
79. Zhu, H.; Jia, Z.; Mahaney, J.E.; Ross, D.; Misra, H.P.; Trush, M.A.; Li, Y. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger. Cardiovasc. Toxicol., 2007, 7(3), 202-211.
80. Siegel, D.; Bolton, E.M.; Burr, J.A.; Liebler, D.C.; Ross, D. The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol. Pharmacol., 1997, 52(2), 300-305.
81. Ferrante, R.J.; Andreassen, O.A.; Dedeoglu, A.; Ferrante, K.L.; Jenkins, B.G.; Hersch, S.M.; Beal, M.F. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci., 2002, 22(5), 1592-1599.
82. Beal, M.F.; Matthews, R.T.; Tieleman, A.; Shults, C.W. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3, tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res., 1998, 783(1), 109-114.
83. Schulke, S.; Dreidax, D.; Malik, A.; Burmester, T.; Nevo, E.; Band, M.; Avivi, A.; Hankeln, T. Living with stress: Regulation of antioxidant defense genes in the subterranean, hypoxia-tolerant mole rat, Spalax. Gene, 2012, 500(2), 199-206.
84. Kaspar, J.W.; Niture, S.K.; Jaiswal, A.K. Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression. J. Cell. Sci., 2012, 125(Pt 4), 1027-1038.
85. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 1997, 237(3), 527-531.
86. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci., 1996, 16(3), 1066-1071.
87. Singh, S.; Padovani, D.; Leslie, R.A.; Chiku, T.; Banerjee, R. Relative contributions of cystathionine beta-synthase and gammacystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J. Biol. Chem., 2009, 284(33), 22457-22466.
88. Enokido, Y.; Suzuki, E.; Iwasawa, K.; Namekata, K.; Okazawa, H.; Kimura, H. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J., 2005, 19(13), 1854-1856.
89. Robert, K.; Vialard, F.; Thiery, E.; Toyama, K.; Sinet, P.M.; Janel, N.; London, J. Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J. Histochem. Cytochem., 2003, 51(3), 363-371.
90. Kimura, Y.; Dargusch, R.; Schubert, D.; Kimura, H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox. Signal., 2006, 8(3-4), 661-670.
91. Kimura, Y.; Kimura, H. Hydrogen sulfide protects neurons from oxidative stress. FASEB. J., 2004, 18(10), 1165-1167.
92. Calvert, J.W.; Elston, M.; Nicholson, C.K.; Gundewar, S.; Jha, S.; Elrod, J.W.; Ramachandran, A.; Lefer, D.J. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemiainduced heart failure in mice. Circulation, 2010, 122(1), 11-19.
93. Calvert, J.W.; Jha, S.; Gundewar, S.; Elrod, J.W.; Ramachandran, A.; Pattillo, C.B.; Kevil, C.G.; Lefer, D.J. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res., 2009, 105(4), 365-374.
94. Tenhunen, R.; Marver, H.S.; Schmid, R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem., 1969, 244(23), 6388-6394.
95. Maines, M.D. The heme oxygenase system: update 2005. Antioxid. Redox. Signal., 2005, 7(11-12), 1761-1766.
96. Abraham, N.G.; Kappas, A. Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med., 2005, 39(1), 1-25.
97. Liu, X.M.; Peyton, K.J.; Ensenat, D.; Wang, H.; Schafer, A.I.; Alam, J.; Durante, W. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle role in cell survival. J. Biol. Chem., 2005, 280(2), 872-877.
98. Lee, B.S.; Heo, J.; Kim, Y.M.; Shim, S.M.; Pae, H.O.; Kim, Y.M.; Chung, H.T. Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem. Biophys. Res. Commun., 2006, 343(3), 965-972.
99. Wang, B.; Cao, W.; Biswal, S.; Dore, S. Carbon monoxideactivated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke., 2011, 42(9), 2605-2610.
100. Suliman, H.B.; Carraway, M.S.; Tatro, L.G.; Piantadosi, C.A. A new activating role for CO in cardiac mitochondrial biogenesis. J. Cell Sci., 2007, 120(Pt 2), 299-308.
101. Zuckerbraun, B.S.; Chin, B.Y.; Bilban, M.; d'Avila, J.C.; Rao, J.; Billiar, T.R.; Otterbein, L.E. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J., 2007, 21(4), 1099-1106.
102. Piantadosi, C.A.; Sylvia, A.L.; Jobsis-Vandervliet, F.F. Differences in brain cytochrome responses to carbon monoxide and cyanide in vivo. J. Appl. Physiol., 1987, 62(3), 1277-1284.
103. Lange-Asschenfeldt, C.; Raval, A.P.; Dave, K.R.; Mochly-Rosen, D.; Sick, T.J.; Perez-Pinzon, M.A. Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J. Cereb. Blood. Flow. Metab., 2004, 24(6), 636-645.
104. Raval, A.P.; Dave, K.R.; Mochly-Rosen, D.; Sick, T.J.; Perez-Pinzon, M.A. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J. Neurosci., 2003, 23(2), 384-391.
105. Hausenloy, D.J.; Wynne, A.M.; Yellon, D.M. Ischemic preconditioning targets the reperfusion phase. Basic Res. Cardiol., 2007, 102(5), 445-452.
106. Liu, Y.; Yang, X.M.; Iliodromitis, E.K.; Kremastinos, D.T.; Dost, T.; Cohen, M.V.; Downey, J.M. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res. Cardiol., 2008, 103(1), 54-59.
107. Gopalakrishna, R.; Anderson, W.B. Ca2+-and phospholipidindependent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. U. S. A., 1989, 86(17), 6758-6762.
108. Gopalakrishna, R.; Anderson, W.B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys., 1991, 285(2), 382-387.
109. Gopalakrishna, R.; Jaken, S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med., 2000, 28(9), 1349-1361.
110. Min, D.S.; Kim, E.G.; Exton, J.H. Involvement of tyrosine phosphorylation and protein kinase C in the activation of phospholipase D by H2O2 in Swiss 3T3 fibroblasts. J. Biol. Chem., 1998, 273(45), 29986-29994.
111. Natarajan, V.; Taher, M.M.; Roehm, B.; Parinandi, N.L.; Schmid, H.H.; Kiss, Z.; Garcia, J.G. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J. Biol. Chem., 1993, 268(2), 930-937.
112. Finkel, T.; Deng, C.X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature, 2009, 460(7255), 587-591.
113. Raval, A.P.; Dave, K.R.; Perez-Pinzon, M.A. Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood. Flow. Metab., 2006, 26(9), 1141-1147.
114. Della-Morte, D.; Dave, K.R.; DeFazio, R.A.; Bao, Y.C.; Raval, A.P.; Perez-Pinzon, M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience, 2009, 159(3), 993-1002.
115. Nadtochiy, S.M.; Yao, H.; McBurney, M.W.; Gu, W.; Guarente, L.; Rahman, I.; Brookes, P.S. SIRT1-mediated acute cardioprotection. Am. J. Physiol. Heart Circ. Physiol., 2011, 301(4), H1506-1512.
116. Nadtochiy, S.M.; Redman, E.; Rahman, I.; Brookes, P.S. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc. Res., 2011, 89(3), 643-649.
117. Hsu, C.P.; Zhai, P.; Yamamoto, T.; Maejima, Y.; Matsushima, S.; Hariharan, N.; Shao, D.; Takagi, H.; Oka, S.; Sadoshima, J. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation, 2010, 122(21), 2170-2182.
118. Prozorovski, T.; Schulze-Topphoff, U.; Glumm, R.; Baumgart, J.; Schroter, F.; Ninnemann, O.; Siegert, E.; Bendix, I.; Brustle, O.; Nitsch, R.; Zipp, F.; Aktas, O. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat. Cell. Biol., 2008, 10(4), 385-394.
119. Chen, R.; Dioum, E.M.; Hogg, R.T.; Gerard, R.D.; Garcia, J.A. Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J. Biol. Chem., 2011, 286(16), 13869-13878.
120. Caito, S.; Rajendrasozhan, S.; Cook, S.; Chung, S.; Yao, H.; Friedman, A.E.; Brookes, P.S.; Rahman, I. SIRT1 is a redoxsensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J., 2010, 24(9), 3145-3159.
121. Zhang, J.; Feng, R.; Feng, X.; Sun, Y.H.; Wang, L.H.; Zhao, Z.Q.; Guo, M.J.; Yang, B.; Li, W.X.; Jing, Z.P. Aneurysm repair in vitro and renal revascularization and renal autogenous transplantation for complex renal artery aneurysm in solitary kidney. Zhonghua Wai Ke Za Zhi, 2007, 45(18), 1253-1256.
122. Sablina, A.A.; Budanov, A.V.; Ilyinskaya, G.V.; Agapova, L.S.; Kravchenko, J.E.; Chumakov, P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med., 2005, 11(12), 1306-1313.
123. Vaziri, H.; Dessain, S.K.; Ng Eaton, E.; Imai, S.I.; Frye, R.A.; Pandita, T.K.; Guarente, L.; Weinberg, R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 2001, 107(2), 149-159.
124. Luo, J.; Nikolaev, A.Y.; Imai, S.; Chen, D.; Su, F.; Shiloh, A.; Guarente, L.; Gu, W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 2001, 107(2), 137-148.
125. Brunet, A.; Sweeney, L.B.; Sturgill, J.F.; Chua, K.F.; Greer, P.L.; Lin, Y.; Tran, H.; Ross, S.E.; Mostoslavsky, R.; Cohen, H.Y.; Hu, L.S.; Cheng, H.L.; Jedrychowski, M.P.; Gygi, S.P.; Sinclair, D.A.; Alt, F.W.; Greenberg, M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 2004, 303(5666), 2011-2015.
126. Wang, F.; Nguyen, M.; Qin, F.X.; Tong, Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell., 2007, 6(4), 505-514.
127. Kops, G.J.; Dansen, T.B.; Polderman, P.E.; Saarloos, I.; Wirtz, K.W.; Coffer, P.J.; Huang, T.T.; Bos, J.L.; Medema, R.H.; Burgering, B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature, 2002, 419(6904), 316-321.
128. Hasegawa, K.; Wakino, S.; Yoshioka, K.; Tatematsu, S.; Hara, Y.; Minakuchi, H.; Washida, N.; Tokuyama, H.; Hayashi, K.; Itoh, H. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun., 2008, 372(1), 51-56.
129. Alcendor, R.R.; Gao, S.; Zhai, P.; Zablocki, D.; Holle, E.; Yu, X.; Tian, B.; Wagner, T.; Vatner, S.F.; Sadoshima, J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res., 2007, 100(10), 1512-1521.
130. Semenza, G.L. Hypoxia-inducible factors in physiology and medicine. Cell, 2012, 148(3), 399-408.
131. Compernolle, V.; Brusselmans, K.; Acker, T.; Hoet, P.; Tjwa, M.; Beck, H.; Plaisance, S.; Dor, Y.; Keshet, E.; Lupu, F.; Nemery, B.; Dewerchin, M.; Van Veldhoven, P.; Plate, K.; Moons, L.; Collen, D.; Carmeliet, P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med., 2002, 8(7), 702-710.
132. Yan, J.; Zhou, B.; Taheri, S.; Shi, H. Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke. PLoS One, 2011, 6(11), e27798.
133. Oladipupo, S.; Hu, S.; Kovalski, J.; Yao, J.; Santeford, A.; Sohn, R.E.; Shohet, R.; Maslov, K.; Wang, L.V.; Arbeit, J.M. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proc. Natl. Acad. Sci., U. S. A., 2011, 108(32), 13264-13269.
134. Jones, N.M.; Bergeron, M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cereb. Blood Flow. Metab., 2001, 21(9), 1105-1114.
135. Foxler, D.E.; Bridge, K.S.; James, V.; Webb, T.M.; Mee, M.; Wong, S.C.; Feng, Y.; Constantin-Teodosiu, D.; Petursdottir, T.E.; Bjornsson, J.; Ingvarsson, S.; Ratcliffe, P.J.; Longmore, G.D.; Sharp, T.V. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat. Cell. Biol., 2012, 14(2), 201-208.
136. Zhang, H.; Bosch-Marce, M.; Shimoda, L.A.; Tan, Y.S.; Baek, J.H.; Wesley, J.B.; Gonzalez, F.J.; Semenza, G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem., 2008, 283(16), 10892-10903.
137. Metzen, E.; Stiehl, D.P.; Doege, K.; Marxsen, J.H.; Hellwig-Burgel, T.; Jelkmann, W. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem. J., 2005, 387(Pt 3), 711-717.
138. Freedman, S.J.; Sun, Z.Y.; Poy, F.; Kung, A.L.; Livingston, D.M.; Wagner, G.; Eck, M.J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci., U. S. A., 2002, 99(8), 5367-5372.
139. Elkins, J.M.; Hewitson, K.S.; McNeill, L.A.; Seibel, J.F.; Schlemminger, I.; Pugh, C.W.; Ratcliffe, P.J.; Schofield, C.J. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. J. Biol. Chem., 2003, 278(3), 1802-1806.
140. Hewitson, K.S.; McNeill, L.A.; Riordan, M.V.; Tian, Y.M.; Bullock, A.N.; Welford, R.W.; Elkins, J.M.; Oldham, N.J.; Bhattacharya, S.; Gleadle, J.M.; Ratcliffe, P.J.; Pugh, C.W.; Schofield, C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem., 2002, 277(29), 26351-26355.
141. Fukuda, R.; Zhang, H.; Kim, J.W.; Shimoda, L.; Dang, C.V.; Semenza, G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell., 2007, 129(1), 111-122.
142. Chandel, N.S.; McClintock, D.S.; Feliciano, C.E.; Wood, T.M.; Melendez, J.A.; Rodriguez, A.M.; Schumacker, P.T. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem., 2000, 275(33), 25130-25138.
143. Ball, K.A.; Nelson, A.W.; Foster, D.G.; Poyton, R.O. Nitric oxide produced by cytochrome c oxidase helps stabilize HIF-1alpha in hypoxic mammalian cells. Biochem. Biophys. Res. Commun., 2012, 420(4), 727-732.
144. Li, Q.F.; Xu, H.; Sun, Y.; Hu, R.; Jiang, H. Induction of inducible nitric oxide synthase by isoflurane post-conditioning via hypoxia inducible factor-1alpha during tolerance against ischemic neuronal injury. Brain Res., 2012, 1451, 1-9.
145. Sandau, K.B.; Fandrey, J.; Brune, B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood, 2001, 97(4), 1009-1015.
146. Palmer, L.A.; Gaston, B.; Johns, R.A. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redoxdependent effect of nitrogen oxides. Mol. Pharmacol., 2000, 58(6), 1197-1203.
147. Kimura, H.; Weisz, A.; Kurashima, Y.; Hashimoto, K.; Ogura, T.; D'Acquisto, F.; Addeo, R.; Makuuchi, M.; Esumi, H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood, 2000, 95(1), 189-197.
148. Liu, Y.; Christou, H.; Morita, T.; Laughner, E.; Semenza, G.L.; Kourembanas, S. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer. J. Biol. Chem., 1998, 273(24), 15257-15262.
149. Yasinska, I.M.; Sumbayev, V.V. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett., 2003, 549(1-3), 105-109.
150. Sumbayev, V.V.; Budde, A.; Zhou, J.; Brune, B. HIF-1 alpha protein as a target for S-nitrosation. FEBS. Lett., 2003, 535(1-3), 106-112.
151. Mateo, J.; Garcia-Lecea, M.; Cadenas, S.; Hernandez, C.; Moncada, S. Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and-independent pathways. Biochem. J., 2003, 376(Pt 2), 537-544.
152. Hagen, T.; Taylor, C.T.; Lam, F.; Moncada, S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science, 2003, 302(5652), 1975-1978.
153. Ara, J.; Fekete, S.; Frank, M.; Golden, J.A.; Pleasure, D.; Valencia, I. Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain. Neurobiol. Dis., 2011, 43(2), 473-485.
154. Bergeron, M.; Gidday, J.M.; Yu, A.Y.; Semenza, G.L.; Ferriero, D.M.; Sharp, F.R. Role of hypoxia-inducible factor-1 in hypoxiainduced ischemic tolerance in neonatal rat brain. Ann. Neurol., 2000, 48(3), 285-296.
155. Venugopal, R.; Jaiswal, A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci., U. S. A., 1996, 93(25), 14960-14965.
156. Itoh, K.; Wakabayashi, N.; Katoh, Y.; Ishii, T.; Igarashi, K.; Engel, J.D.; Yamamoto, M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes. Dev., 1999, 13(1), 76-86.
157. Huang, H.C.; Nguyen, T.; Pickett, C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response elementmediated transcription. J. Biol. Chem., 2002, 277(45), 42769-42774.
158. Kawai, Y.; Garduno, L.; Theodore, M.; Yang, J.; Arinze, I.J. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem., 2011, 286(9), 7629-7640.
159. Chan, K.; Han, X.D.; Kan, Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(8), 4611-4616.
160. Reichard, J.F.; Motz, G.T.; Puga, A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic. Acids. Res., 2007, 35(21), 7074-7086.
161. Dreger, H.; Westphal, K.; Weller, A.; Baumann, G.; Stangl, V.; Meiners, S.; Stangl, K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitormediated cardioprotection. Cardiovasc. Res., 2009, 83(2), 354-361.
162. Dong, J.; Sulik, K.K.; Chen, S.Y. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox. Signal., 2008, 10(12), 2023-2033.
163. Papaiahgari, S.; Zhang, Q.; Kleeberger, S.R.; Cho, H.Y.; Reddy, S.P. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid. Redox. Signal., 2006, 8(1-2), 43-52.
164. Habeos, I.G.; Ziros, P.G.; Chartoumpekis, D.; Psyrogiannis, A.; Kyriazopoulou, V.; Papavassiliou, A.G. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J. Mol. Med. (Berl)., 2008, 86(11), 1279-1285.
165. Kikuchi, N.; Ishii, Y.; Morishima, Y.; Yageta, Y.; Haraguchi, N.; Itoh, K.; Yamamoto, M.; Hizawa, N. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir. Res., 2010, 11, 31.
166. Wang, B.; Zhu, X.; Kim, Y.; Li, J.; Huang, S.; Saleem, S.; Li, R.C.; Xu, Y.; Dore, S.; Cao, W. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic. Biol. Med., 2012, 52(5), 928-936.
167. Liverman, C.S.; Cui, L.; Yong, C.; Choudhuri, R.; Klein, R.M.; Welch, K.M.; Berman, N.E. Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization. Brain Res. Mol. Brain Res., 2004, 126(1), 57-66.
168. Um, H.C.; Jang, J.H.; Kim, D.H.; Lee, C.; Surh, Y.J. Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric. Oxide., 2011, 25(2), 161-168.
169. Kumar, A.; Singh, C.K.; Lavoie, H.A.; Dipette, D.J.; Singh, U.S. Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Mol. Pharmacol., 2011, 80(3), 446-457.
170. Bell, K.F.; Al-Mubarak, B.; Fowler, J.H.; Baxter, P.S.; Gupta, K.; Tsujita, T.; Chowdhry, S.; Patani, R.; Chandran, S.; Horsburgh, K.; Hayes, J.D.; Hardingham, G.E. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A., 2011, 108(1), E1-2; author reply E3-4.
171. Bell, K.F.; Fowler, J.H.; Al-Mubarak, B.; Horsburgh, K.; Hardingham, G.E. Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid. Med. Cell. Longev., 2011, 2011, 689524.
172. Yellon, D.M.; Alkhulaifi, A.M.; Pugsley, W.B. Preconditioning the human myocardium. Lancet., 1993, 342(8866), 276-277.
173. Walsh, S.R.; Tang, T.Y.; Kullar, P.; Jenkins, D.P.; Dutka, D.P.; Gaunt, M.E. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur. J. Cardiothorac. Surg., 2008, 34(5), 985-994.
174. Sugimoto, K.; Ito, H.; Iwakura, K.; Ikushima, M.; Kato, A.; Kimura, R.; Tanaka, K.; Masuyama, T.; Ogihara, T.; Kawano, S.; Fujii, K. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ. J., 2003, 67(4), 295-300.
175. Hausenloy, D.J.; Yellon, D.M. The therapeutic potential of ischemic conditioning: an update. Nat. Rev. Cardiol., 2011, 8(11), 619-629.
176. Simao, F.; Matte, A.; Pagnussat, A.S.; Netto, C.A.; Salbego, C.G. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways. Eur. J. Neurosci., 2012. [Epub ahead of print].
177. Simao, F.; Matte, A.; Pagnussat, A.S.; Netto, C.A.; Salbego, C.G. Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia. Neurochem. Int., 2012. [Epub ahead of print].
178. Becatti, M.; Taddei, N.; Cecchi, C.; Nassi, N.; Nassi, P.A.; Fiorillo, C. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell. Mol. Life. Sci., 2012, 69(13), 2245-2260.
179. Girbovan, C.; Morin, L.; Plamondon, H. Repeated resveratrol administration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav. Pharmacol., 2012, 23(1), 1-13.
180. Ren, J.; Fan, C.; Chen, N.; Huang, J.; Yang, Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res., 2011, 36(12), 2352-2362.
181. Usta, E.; Mustafi, M.; Walker, T.; Ziemer, G. Resveratrol suppresses apoptosis in intact human cardiac tissue-in vitro model simulating extracorporeal circulation. J. Cardiovasc. Surg. (Torino)., 2011, 52(3), 399-409.
182. Vlahakos, D.; Arkadopoulos, N.; Kostopanagiotou, G.; Siasiakou, S.; Kaklamanis, L.; Degiannis, D.; Demonakou, M.; Smyrniotis, V. Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs. Artif. Organs, 2012, 36(4), 400-408.
183. Xing, Y.; Hua, Y.; Keep, R.F.; Xi, G. Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia. Brain Res., 2009, 1291, 113-121.
184. van der Kooij, M.A.; Groenendaal, F.; Kavelaars, A.; Heijnen, C.J.; van Bel, F. Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat? Neurosci. Lett., 2009, 451(2), 109-113.
185. Luciano, J.A.; Tan, T.; Zhang, Q.; Huang, E.; Scholz, P.; Weiss, H.R. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell. Physiol. Biochem., 2008, 21(5-6), 421-428.
186. Sivaraman, V.; Hausenloy, D.J.; Kolvekar, S.; Hayward, M.; Yap, J.; Lawrence, D.; Di Salvo, C.; Yellon, D.M. The divergent roles of protein kinase C epsilon and delta in simulated ischaemiareperfusion injury in human myocardium. J. Mol. Cell. Cardiol., 2009, 46(5), 758-764.
187. Della-Morte, D.; Raval, A.P.; Dave, K.R.; Lin, H.W.; Perez-Pinzon, M.A. Post-ischemic activation of protein kinase C epsilon protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flow. Neurosci. Lett., 2011, 487(2), 158-162.
188. Bright, R.; Sun, G.H.; Yenari, M.A.; Steinberg, G.K.; Mochly-Rosen, D. epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci. Lett., 2008, 441(1), 120-124.